Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aa388e460f6cf478bd46c925c6ab10e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-01003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-182 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2016-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_842aa775284573755221e5276c2abfc7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4ba041a022b958506360c78f509b6b3 |
publicationDate |
2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2016132341-A1 |
titleOfInvention |
A process for the preparation of tofacitinib citrate |
abstract |
The present invention provides a process for the preparation of tofacitinib citrate of Formula I. Specifically, the present invention provides an enzymatic route for the preparation of tofacitinib of Formula II, which is converted to tofacitinib citrate of Formula I. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108997355-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110343111-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107814802-A |
priorityDate |
2015-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |